Coverage
-
January 29, 2018
Forest Laboratories Inc. prevailed on Monday against claims by a health and benefit fund and a pair of mothers that it fraudulently promoted Celexa and Lexapro for pediatric depression, putting long-running Massachusetts multidistrict litigation against the company to rest.
13 other articles on this case.
View all »